November 28, 2016
Conférence Biotech Agora – December 13, 2016 18h45 – Hôtel ATALA, 10 Rue de Chateaubriand, 75008
november 22, 2016
BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release
November 15, 2016
Biophytis Presenting Four Posters on Sarconeos at 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting. Read the Press Release
November 09, 2016
BIOPHYTIS to attend to Jefferies conference (London) and European Midcap event (Geneva). Read the Press Release
October 24, 2016
BIOPHYTIS chooses Patheon to produce the clinical batches of Macuneos, its AMD drug candidate that will enter Phase 2B. Read the Press Release
October 11, 2016
BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release
October 04, 2016
Biophytis to attend the European Large & Midcap Event in Paris – 5-6 October, 2016
03 october 2016
Video interview of Stanislas Veillet, CEO of Biophytis. Click here to see it
September 29, 2016
Business Update and Consolidated Half-Year Financials as of June 30, 2016. Read the Press Release
September 22, 2016
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release